| Continual evolution of type 2 diabetes: an update on pathophysiology and emerging treatment options S Cornell Therapeutics and clinical risk management, 621-632, 2015 | 103 | 2015 |
| A review of GLP‐1 receptor agonists in type 2 diabetes: a focus on the mechanism of action of once‐weekly agents S Cornell Journal of clinical pharmacy and therapeutics 45, 17-27, 2020 | 73 | 2020 |
| Interprofessional workshop to improve mutual understanding between pharmacy and medical students LJ Van Winkle, BC Bjork, N Chandar, S Cornell, N Fjortoft, JM Green, ... American Journal of Pharmaceutical Education 76 (8), 150, 2012 | 57 | 2012 |
| Differentiating among incretin therapies: a multiple‐target approach to type 2 diabetes S Cornell Journal of Clinical Pharmacy and Therapeutics 37 (5), 510-524, 2012 | 52 | 2012 |
| Critical thinking and reflection exercises in a biochemistry course to improve prospective health professions students’ attitudes toward physician-pharmacist collaboration LJ Van Winkle, S Cornell, N Fjortoft, BC Bjork, N Chandar, JM Green, ... American Journal of Pharmaceutical Education 77 (8), 169, 2013 | 46 | 2013 |
| Comparison of the diabetes guidelines from the ADA/EASD and the AACE/ACE S Cornell Journal of the American Pharmacists Association 57 (2), 261-265, 2017 | 42 | 2017 |
| Self-monitoring blood glucose (SMBG): now and the future AL Briggs, S Cornell Journal of Pharmacy Practice 17 (1), 29-38, 2004 | 40 | 2004 |
| Canagliflozin treatment in patients with type 2 diabetes mellitus C Triplitt, S Cornell Clinical Medicine Insights: Endocrinology and Diabetes 8, CMED. S31526, 2015 | 30 | 2015 |
| Diabetes pharmacotherapy in 2012: considerations in medication selection S Cornell, VJ Dorsey Postgraduate Medicine 124 (4), 84-94, 2012 | 29 | 2012 |
| Newer treatment strategies for the management of type 2 diabetes mellitus S Cornell, A Briggs Journal of Pharmacy Practice 17 (1), 49-54, 2004 | 24 | 2004 |
| The art and science of diabetes self-management education desk reference C Mensing, S Cornell, C Halstenson Chicago, IL: American Association of Diabetes Educators 110, 2014 | 21 | 2014 |
| Key considerations in pharmacotherapy for type 2 diabetes mellitus: a multiple target organ approach S Cornell Journal of clinical pharmacy and therapeutics 37 (3), 254-259, 2012 | 8 | 2012 |
| Pharmacotherapy considerations in diabetes and obesity: setting patients up for success S Cornell, J D'Souza Postgraduate Medicine 126 (2), 100-109, 2014 | 7 | 2014 |
| Managing diabetes-related costs and quality of life issues: Value of insulin analogs and pens for inpatient use S Cornell Health policy 96 (3), 191-199, 2010 | 7 | 2010 |
| Getting to goal for patients with type 2 diabetes: mission possible S Cornell, A Lullo Diabetes Trends 21 (Suppl A), 3-11, 2009 | 7 | 2009 |
| Type 2 diabetes treatment recommendations update: Appropriate use of dipeptidyl peptidase-4 inhibitors S Cornell J Diabetes Metab 5 (414), 2, 2014 | 6 | 2014 |
| The art and science of diabetes care and education S Cornell, C Halstenson, DK Miller Association of Diabetes Care & Education Specialists, 2021 | 4 | 2021 |
| A patient‐centred approach to treatment with incretin‐based agents in patients with type 2 diabetes SA Cornell Journal of clinical pharmacy and therapeutics 38 (3), 181-189, 2013 | 4 | 2013 |
| The Art and Science of Diabetes Self-Management Education Desk Reference S Cornell, C Halstenson, D Miller American Association of a Diabetes Educators 4, 703, 2011 | 4 | 2011 |
| Medication Management in Type 2 Diabetes. SD Burke, SA Cornell Clinician Reviews 18 (3), 2008 | 3 | 2008 |
